http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0133218-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
filingDate 1984-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1988-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1988-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0133218-B1
titleOfInvention Endo-8,8-dialkyl-8-azoniabicyclo (3.2.1) octane-6,7-exo-epoxy-3-alkyl-carboxylate salts, a process for their preparation, and therapeutic compositions which contain them as active principle
abstract The invention relates to new products, namely endo-8,8-dialkyl-8-azoniabicyclo [3.2.1] octane-6,7-exo-epoxy-3-alkylcarboxylates, of formula:in which R, and R<sub>2</sub>, which can be the same or different, are linear or branched alkyl radicals of 1-5 C atoms or cycloalkyl radicals of 3-6 C atoms;R<sub>3</sub> and R<sub>4</sub>, which can be the same or differend, are alkyl radicals of 1-6 C atoms;X<sup>-</sup> is a halide ion.The new compounds are powerful spasmolytics.
priorityDate 1983-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12959398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227544037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID673473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23616082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6852391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226574264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226837892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226574265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468345173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87063
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21703231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427085
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422905
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466721132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187

Total number of triples: 40.